NEW Zealand's healthcare
industry is being restrained by
the country's Pharmaceutical
Management Agency's
(PHARMAC) emphasis on
generics, according to GlobalData
research.
The report forecasts NZ's
pharmaceutical market to reach a
value of US$779m in 2020 from
US$587m in 2012 - representing a
Compound Annual Growth Rate
(CAGR) of 4%.
Revenue would be more
impressive with a greater
integration of multinational
pharmaceutical firms,”
GlobalData said.
In addition GlobalData said the
nation’s elderly population will be
an important factor in the
country’s healthcare sector
revenue, with statistics showing
the number of kiwis over 65
between 2012 and 2020 will
climb from 13.6% to 16.2%.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Feb 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Feb 13
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.